Fig. 4: LINE-1 ORF1p is detectable in CCOC patient blood samples.

A Circulating plasma ORF1p levels detected by two Simoa assays (34H7::Nb5-5LL left and 62H12::Ab6 right) in control (N = 50) and CCOC patients (n = 5). B Circulating serum ORF1p levels detected by two Simoa assays (34H7::Nb5-5LL left and 62H12::Ab6 right) in control (N = 10) and CCOC patients (n = 16). Patients’ cancer stages depicted when reported. LOD Limit of detection.